THE IMPACT OF OBESITY ON SERUM ALBUMIN LEVELS IN ADULTS WITHOUT LIVER OR KIDNEY DYSFUNCTION
Main Article Content
Keywords
Obesity, Circulating Albumin, A Body Mass Index, Cross-sectional, Health Marker, Inflammation.
Abstract
Objectives: The sample selected for this study were obese adults with a BMI over 30, with no clinically apparent liver or kidney disease, to assess the relationship between BMI and serum albumin as a possible indicator of health state.
Materials and Methods: A survey was carried out with 200 adults selected from the population, ages ranging between 18 and 65.
Participants were categorized into BMI categories: obesity, overweight, and various levels of obesity. Participants donated blood samples to determine sub-joint serum albumin levels and demographic information was recorded. Various mathematical reports and regressions were conducted to determine the correlation between BMI and serum albumin.
Results: The study established that BMI was negatively related to serum albumin, with serum albumin reducing as BMI augmented. The overall mean serum albumin was 4.0g/dL, and as expected, this had a negative association with BMI, as patients in the higher BMI categories reported lower levels.
Conclusion: The study's findings stress the need for measuring serum albumin to assess obesity risk factors among adults who do not have liver and kidney diseases.
References
2. Milano, W., Carizzone, F., Foia, M., Marchese, M., Milano, M., Saetta, B., & Capasso, A. (2022). Obesity and its multiple clinical implications between inflammatory states and gut microbiotic alterations. Diseases, 11(1), 7.
3. Martin, W.P., White, J., López-Hernández, F.J., Docherty, N.G. and Le Roux, C.W., 2020. Metabolic surgery to treat obesity in diabetic kidney disease, chronic kidney disease, and end-stage kidney disease; what are the unanswered questions?. Frontiers in Endocrinology, 11, p.289.
4. Luli, M., Yeo, G., Farrell, E., Ogden, J., Parretti, H., Frew, E., Bevan, S., Brown, A., Logue, J., Menon, V., & Isack, N. (2023). The implications of defining obesity as a disease: a report from the Association for the Study of Obesity 2021 annual conference. EClinicalMedicine, 58.
5. Ren, J., Wu, N.N., Wang, S., Sowers, J.R., & Zhang, Y. (2021). Obesity cardiomyopathy: evidence, mechanisms, and therapeutic implications. Physiological Reviews, 101(4), 1745-1807.
6. Rabbani, G., & Ahn, S.N. (2021). Roles of human serum albumin in prediction, diagnoses, and treatment of COVID-19. International Journal of Biological Macromolecules, 193, 948-955.
7. Eckart, A., Struja, T., Kutz, A., Baumgartner, A., Baumgartner, T., Zurfluh, S., Neeser, O., Huber, A., Stanga, Z., Mueller, B., & Schuetz, P. (2020). Relationship of nutritional status, inflammation, and serum albumin levels during acute illness: a prospective study. The American Journal of Medicine, 133(6), 713-722.
8. Stefania, D.S., Clodoveo, M.L., Cariello, M., D’Amato, G., Franchini, C., Faienza, M.F. and Corbo, F., 2021. Polyphenols and obesity prevention: Critical insights on molecular regulation, bioavailability and dose in preclinical and clinical settings. Critical Reviews in Food Science and Nutrition, 61(11), pp.1804-1826.
9. Huang, W., Li, C., Wang, Z., Wang, H., Zhou, N., Jiang, J., Ni, L., Zhang, X.A., & Wang, D.W. (2020). Decreased serum albumin level indicates poor prognosis of COVID-19 patients: hepatic injury analysis from 2,623 hospitalized cases. Science China Life Sciences, 63, 1678-1687.
10. Yang, Z., Zheng, Y., Wu, Z., Wen, Y., Wang, G., Chen, S., Tan, F., Li, J., Wu, S., Dai, M., & Li, N. (2021). Association between pre‐diagnostic serum albumin and cancer risk: Results from a prospective population‐based study. Cancer Medicine, 10(12), 4054-4065.
11. Abdeen, Y., Kaako, A., Ahmad Amin, Z., Muhanna, A., Josefine Froessl, L., Alnabulsi, M., Okeh, A., & Miller, R.A. (2021). The Prognostic Effect of Serum Albumin Level on Outcomes of Hospitalized COVID‐19 Patients. Critical Care Research and Practice, 2021(1), 9963274.
12. Fan, Y., Li, X., Xu, Q., Zhang, Y., Yang, X., Han, X., Du, G., Xia, Y., Wang, X., & Lu, C. (2020). Serum albumin mediates the effect of multiple per-and polyfluoroalkyl substances on serum lipid levels. Environmental Pollution, 266, 115138.